RxDoctor Payments Data

Robert Pozzi, DO

Family Medicine · Saint Louis, MONPI 1518948900

Payments from drug & device makers

$14,572in general payments, 2019–2025

Across 944 payments — averaging $15.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • GSK$1K
  • Pfizer$1K
  • Novo Nordisk$1K
  • Lilly USA, LLC$1K
  • Boehringer Ingelheim$906
  • plus $7K from 51 others

What the payments were for

  • Food & beverage$14,34198%
  • Education$2151%
  • Entertainment$150%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)94$1,489
GSK106$1,488
Pfizer100$1,404
Novo Nordisk98$1,347
Lilly USA, LLC66$1,032
Boehringer Ingelheim62$906
Takeda Pharmaceuticals U.S.A., Inc.42$673
AstraZeneca34$670
Astellas Pharma US Inc25$581
Amgen24$399
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC22$321
E.r. Squibb & Sons, L.L.C.19$307
Johnson & Johnson14$245
Novartis16$243
Sanofi-aventis U.S. LLC15$220
Daiichi Sankyo Inc.12$207
Exact Sciences10$194
Kowa Pharmaceuticals America, Inc.12$162
Gilead10$159
Amarin Pharma, Inc.12$156
Biohaven Pharmaceuticals, Inc.13$154
Insulet Corporation5$151
Dexcom, Inc.9$149
Axsome Therapeutics, Inc.8$149
Scilex Pharmaceuticals Inc.9$141
Biohaven Pharmaceutical Holding Company Ltd.17$128
Viiv Healthcare Company7$124
Merck8$117
Sanofi Pasteur Inc.7$112
Otsuka America Pharmaceutical, Inc.6$108
Abbott5$102
Teva Pharmaceuticals USA, Inc.5$76
Shire North American Group Inc4$60
Verona Pharma, Inc.3$51
Sunovion Pharmaceuticals Inc.3$51
Optinose US, Inc.3$51
Supernus Pharmaceuticals, Inc.3$50
Ironshore Pharmaceuticals Inc.3$49
Acerus Pharmaceuticals Corporation3$48
Paratek Pharmaceuticals, Inc.3$48
Mylan Specialty L.p.3$46
Bayer3$42
Sumitomo Pharma America, Inc.2$35
Idorsia Pharmaceuticals US Inc2$32
Xeris Pharmaceuticals, Inc.2$32
Corcept Therapeutics2$31
Adlon Therapeutics L.p.2$28
Pharmacosmos Therapeutics Inc.1$27
Esperion Therapeutics, Inc.2$27
Itamar Medical Inc1$27
Phathom Pharmaceuticals, Inc.1$23
Bausch Health US, LLC1$23
Grifols USA, LLC1$17
Lundbeck LLC1$16
Optos, Inc.1$15
Genentech USA, Inc.1$15
Eisai Inc.1$13

How this compares

$14,572 in reported general payments places this provider in the 95th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$33,128
Medicare patients
90
Services billed
1,058

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide153$174,676
Trelegy ElliptaFluticasone/Umeclidin/Vilanter93$63,738
EliquisApixaban99$60,015
JardianceEmpagliflozin70$50,953
ArexvyRsvpref3 Antigen/As01e/Pf118$34,156
JanuviaSitagliptin Phosphate31$20,788
XareltoRivaroxaban29$15,850
Breztri AerosphereBudesonide/Glycopyr/Formoterol24$15,196
MyrbetriqMirabegron31$15,167
FarxigaDapagliflozin Propanediol20$14,691
TradjentaLinagliptin22$13,906
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog23$11,525
Breo ElliptaFluticasone/Vilanterol21$8,501
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr16$7,344
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen285$6,145

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$1,347$174,676153 claims
GSKTrelegy Ellipta, Arexvy, Breo Ellipta, Anoro Ellipta$1,488$113,740248 claims
Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat$906$70,001103 claims
PfizerEliquis, Premarin$1,404$61,560110 claims
AstraZenecaBreztri Aerosphere, Farxiga$670$29,88744 claims
MerckJanuvia$117$20,78831 claims
Johnson & JohnsonXarelto$245$15,85029 claims
Astellas Pharma US IncMyrbetriq$581$15,16731 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Louis

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →